Top

Neurocritical Care

Published in:

01-04-2012 | Original Article

High-dose Ambroxol Reduces Pulmonary Complications in Patients with Acute Cervical Spinal Cord Injury After Surgery

Authors: Qiang Li, Gaiqi Yao, Xi Zhu

Published in: Neurocritical Care | Issue 2/2012

Abstract

Background

Ambroxol has a very high affinity for lung tissues; its concentration is approximately 20 times higher in the lung than in the serum. We aimed to evaluate the effectiveness of high-dose ambroxol (990 mg/day) in the improvement of oxygenation and prevention of postoperative respiratory complications in the patients with acute cervical spinal cord injury (CSCI).

Methods

A total of 61 acute CSCI patients admitted to the Intensive Care Unit (ICU) of our hospital between January 2009 and June 2011 were included in the study. They were graded as ASIA A and ASIA B according to the classification of the American Spinal Injury Association (ASIA) and were randomly divided into two groups: one group received intravenous ambroxol at 990 mg/day for 5 consecutive days after operation; the other group treated without ambroxol served as control. The results of arterial blood gas analysis on postoperative day 3 and 5 and occurrence of pulmonary complications within 5 days after operation were evaluated.

Results

The group treated with high-dose ambroxol showed a lower rate of postoperative pneumonia and hypoxemia within 5 days after operation. On the 3rd and 5th days, the oxygenation index in the high-dose ambroxol group (291.02 ± 34.96 and 301.28 ± 37.69) was significantly higher than in the control group (230.08 ± 26.25 and 253.82 ± 26.26), with significant differences between the two groups (P = 0.045 and 0.041).

Conclusion

Administration of high-dose ambroxol should be considered as an alternative and effective approach to reduce the postoperative respiratory complications and improve the oxygenation status in acute CSCI patients.

Romanini BM, Sandri MG, Tosi M, Mezzetti M, Mazzetti A. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery. Int J Clin Pharmacol Res. 1986;6:123–7.PubMed

Fegiz G. Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo. Lung. 1991;169:69–76.PubMedCrossRef

Refai M, Brunelli A, Xiumé F, Salati M, Sciarra V, Socci L, et al. Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial. Eur J Cardiothorac Surg. 2009;35:469–73.PubMedCrossRef

Ulas MM, Hizarci M, Kunt A, Ergun K, Kocabeyoglu SS, Korkmaz K, et al. Protective effect of Ambroxol on pulmonary function after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2008;52(6):518–23.PubMedCrossRef

Marino RJ, Barros T, Biering-Sorensen F, Burns SP, Donovan WH, Graves DE. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2003;26(Suppl 1):S50–6.PubMed

Velmahos GC, Toutouzas K, Chan L, Tillou A, Rhee P, Murray J, et al. Intubation after cervical spinal cord injury: to be done selectively or routinely? Am Surg. 2003;69:891–4.PubMed

DeVivo MJ, Stover SL. Long-term survival and causes of death. In: Stover SL, Dehisa JA, Whiteneck G, editors. Spinal Cord Injury : Clinical Outcomes from the Model Systems. Gaithersburg: Aspen; 1995. p. 289–316.

Carter RE. Unilateral diaphragmatic paralysis in spinal cord injury patients. Paraplegia. 1980;28:267–73.CrossRef

Axen K, Pineda H, Shunfenthal I, Haas F. Diaphragmatic function following cervical cord injury : neurally mediated improvement. Arch Phys Med Rehabil. 1985;66:219–22.PubMedCrossRef

10.

Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians. 1988;110:482–8.

11.

Vreugdenhil HA, Heijnen CJ, Plötz FB, Zijlstra J, Jansen NJ, Haitsma JJ, Lachmann B, van Vught AJ. Mechanical ventilation of healthy rats suppresses peripheral immune function. Eur Respir J. 2004;23:122–8.PubMedCrossRef

12.

Ericsson CH, Juhász J, Mossberg B, Philipson K, Svartengren M, Camner P. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol. 1998;275(6 Pt 1):L1040–50.

13.

Vlahakis NE, Schroeder MA, Limper AH, Hubmayr RD. Stretch induces cytokine release by alveolar epithelia cells in vitro. Am J Physiol. 1999;277(1 Pt 1):L167–73.PubMed

14.

Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest. 1997;99:944–52.PubMedCrossRef

15.

Wrigge H, Uhlig U, Baumgarten G, Menzenbach J, Zinserling J, Ernst M, Dromann D. Mechanical ventilation strategies and inflammatory responses to cardiac surgery: a prospective randomized clinical trial. Intensive Care Med. 2005;31:1379–87.PubMedCrossRef

16.

Michelet P, D’Journo XB, Roch A, Doddoli C, Marin V, Papazian L, et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology. 2006;105:911–9.PubMedCrossRef

17.

Wolthuis EK, Choi G, Dessing MC, Bresser P, Lutter R, Dzoljic M. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108:46–54.PubMedCrossRef

18.

Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1–6.PubMedCrossRef

19.

Gajic O, Dara SI, Mendez JL, Adesanya AO, Festic E, Caples SM, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med. 2004;32:1817–24.PubMedCrossRef

20.

Wolthuis EK, Choi G, Dessing MC, Bresser P, Lutter R, Dzoljic M, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108:46–54.PubMedCrossRef

21.

Determann RM, Wolthuis EK, Choi G, Bresser P, Bernard A, Lutter R, et al. Lung epithelial injury markers are not influenced by use of lower tidal volumes during elective surgery in patients without preexisting lung injury. Am J Physiol. 2008;294:L344–50.

22.

Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O. What tidal volumes should be used in patients without acute lung injury? Anesthesiology. 2007;106:1226–31.PubMedCrossRef

23.

Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A. Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med. 2005;31:922–6.PubMedCrossRef

24.

25.

Pfeifer S, Zissel G, Kienast K, Muller-Quernheim J. Reduction of cytokine release from blood and bronchoalveolar mononuclear cells by ambroxol. Eur J Med Res. 1997;2:129–32.PubMed

26.

Gibbs BF, Schmutzler W, Vollrath IB, Brosthardt P, Braam U, Wolff HH, et al. Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res. 1999;48:86–93.PubMedCrossRef

27.

Beeh KM, Beier J, Esperester A, Paul LD. Antiinflammatory properties of ambroxol. Eur J Med Res. 2008;13:557–62.PubMed

28.

Su X, Wang L, Song Y, Bai C. Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide. Intensive Care Med. 2004;30:133–40. [Epub 2003 Sep 20].PubMedCrossRef

29.

Paganin F, Bouvet O, Chanez P, Fabre D, Galtier M, Godard P, et al. Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation. Biopharm Drug Dispos. 1995;16:393–401.PubMedCrossRef

30.

Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M. Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus domase alfa. Arch-Pediatr. 1998;5:371–7.PubMedCrossRef

31.

Gené R, Poderoso JJ, Corazza C, Lasala MB, Wiemeyer JC, Fernández M, et al. Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid. Arzneimittelforschung. 1987;37:967–8.PubMed

32.

Spátola J, Poderoso JJ, Wiemeyer JC, Fernández M, Guerreiro RB, Corazza C. Influence of ambroxol on lung tissue penetration of amoxicillin. Arzneimittelforschung. 1987;37:965–6.PubMed

33.

Wiemeyer JC. Influence of ambroxol on the bronchopulmonary level of antibiotics. Arzneimittelforschung. 1981;31:974–6.PubMed

34.

Li F, Wang W, Hu L, Li L, Yu J. Effect of Ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat model. Chemotherapy. 2011;57:173–80. [Epub 2011 April 1].PubMedCrossRef

35.

Lu Q, Yu J, Yang X, Wang J, Wang L, Lin Y, et al. Ambroxol interferes with Pseudomonas aeruginosa quorum sensing. Int J Antimicrob Agents. 2010;36:211–5. [Epub 2010 Jun 26].PubMedCrossRef

36.

Hafez MM, Aboulwafa MM, Yassien MA, Hassouna NA. Activity of some mucolytics against bacterial adherence to mammalian cells. Appl Biochem Biotechnol. 2009;158:97–112. Epub 2008 Aug 12.PubMedCrossRef

37.

Xie DS, Xiong W, Lai RP, Liu L, Gan XM, Wang XH, et al. Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey. J Hosp Infect. 2011;78:284–8. [Epub 2011 April 20].PubMedCrossRef

Title: High-dose Ambroxol Reduces Pulmonary Complications in Patients with Acute Cervical Spinal Cord Injury After Surgery
Authors: Qiang Li
Gaiqi Yao
Xi Zhu
Publication date: 01-04-2012
Publisher: Humana Press Inc
Published in: Neurocritical Care / Issue 2/2012
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-011-9642-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

High-dose Ambroxol Reduces Pulmonary Complications in Patients with Acute Cervical Spinal Cord Injury After Surgery

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2012

Orthostatic Hypotension Following Resection of a Dorsal Medullary Hemangioblastoma

Potassium Sparing Diuretics as Adjunct to Mannitol Therapy in Neurocritical Care Patients with Cerebral Edema: Effects on Potassium Homeostasis and Cardiac Arrhythmias

Critical Thresholds for Cerebrovascular Reactivity After Traumatic Brain Injury

Obesity is Associated with Reduced Brain Tissue Oxygen Tension After Severe Brain Injury

The Risks of Blood Transfusion in Patients with Subarachnoid Hemorrhage: Response to Dr. Paul E. Marik

Increased Rate of Aspiration Pneumonia and Poor Discharge Outcome Among Acute Ischemic Stroke Patients Following Intubation for Endovascular Treatment